GSK1437173A (Herpes Zoster vaccine)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK1437173A (Herpes Zoster vaccine), covering 2017-07-05 to 2017-07-05. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A When Co-administered With Pneumovax 23™ in Adults Aged 50 Years and Older [Phase 3]